False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up

The American Journal of Surgical Pathology
Tineke WoltersGeert J L H van Leenders

Abstract

Little is known about the frequency, histopathologic characteristics, and clinical consequences of false-negative prostate biopsies, that is, biopsies classified as benign but containing adenocarcinoma or atypical suspicious glands [atypical small acinar proliferations (ASAP)]. Objective of this study was to evaluate false-negative prostate biopsy in a prostate cancer screening setting. Prostate biopsy sets of 196 participants of a screening trial, which had been reported as "benign" at initial diagnosis, followed by a diagnosis of adenocarcinoma in a subsequent screening round were reviewed by 2 urologic pathologists. Adenocarcinoma was identified in 19 biopsy cores corresponding to 16 (8.2%) patients and ASAP in 24 cores, corresponding to 19 patients (9.7%). All missed prostate cancers were Gleason score 6 (3+3). After correction for patient selection, the overall false-negative biopsy rate was estimated to be 2.4%; 1.1% for prostate cancer; and 1.3% for ASAP. Clinicopathologic features at the time of initial biopsy and of subsequent prostate cancer diagnosis did not differ between patients with a false-negative or true benign biopsy. Relatively low number of atypical glands (<10 glands), intense intermingling with preexisten...Continue Reading

References

Apr 1, 1996·The American Journal of Surgical Pathology·R S Nelson, J I Epstein
Feb 1, 1997·The American Journal of Surgical Pathology·J A DiGiuseppeJ I Epstein
Dec 31, 1997·The American Journal of Surgical Pathology·K A IczkowskiD G Bostwick
Aug 10, 2000·The American Journal of Surgical Pathology·A W Levi, J I Epstein
Jan 23, 2003·The Prostate·Joseph D KronzJonathan I Epstein
Apr 30, 2003·Journal of Clinical Pathology·Th H van der KwastUNKNOWN Members of the pathology committee of the European Randomised Study of Screening for Prostate Cancer
Sep 13, 2003·BJU International·D A Diamond
Jan 24, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jonathan I Epstein
Feb 27, 2004·BJU International·T H Van der KwastR F Hoedemaeker
Sep 8, 2005·The Journal of Urology·Theresa Y Chan, Jonathan I Epstein
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators

❮ Previous
Next ❯

Citations

Jun 21, 2013·Der Urologe. Ausg. A·G Kristiansen
Aug 22, 2013·Der Pathologe·G KristiansenT Wiegel
Feb 24, 2011·Current Urology Reports·David A Levy, J Stephen Jones
Apr 19, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Geert J L H van LeendersJan Trapman
May 4, 2011·Prostate Cancer and Prostatic Diseases·M B NicholS J Jacobsen
Mar 31, 2012·Science Translational Medicine·John R PrensnerArul M Chinnaiyan
Mar 20, 2015·Drug Delivery and Translational Research·Christa HaldrupKarina D Sorensen
Jun 3, 2014·Journal of Medical Case Reports·Pasqualino CarginiTommaso Cutilli
Apr 24, 2012·Annales de pathologie·Mathilde Sibony
Mar 29, 2011·Histopathology·Jon D Oxley, Chandan Sen
Jan 4, 2012·Histopathology·Peter A Humphrey
Jun 27, 2014·Diagnostic Cytopathology·Hamide SayarHarun Çıralık
Jul 22, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Verena Sailer, Glen Kristiansen
Nov 28, 2015·Surgical Pathology Clinics·Adebowale J Adeniran, Peter A Humphrey
Jun 27, 2015·International Journal of Experimental Pathology·Huilian HouXu Li
Dec 18, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heidi A van VugtEwout W Steyerberg
Feb 25, 2014·The Journal of Urology·Peter A Humphrey
Apr 25, 2016·European Urology·Leander Van NesteJack A Schalken
Jul 15, 2017·International Journal of Surgical Pathology·Julian Arista-NasrJorge Albores-Saavedra
Jul 21, 2012·Urologia Internationalis·Carmen MaccagnanoVincenzo Scattoni
Sep 9, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Soon Auck HongSoon Chul Myung
Jun 29, 2010·Current Opinion in Urology·J Stephen Jones
Jan 4, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Peter A Humphrey
Jan 7, 2017·Oncotarget·Cristiana Pistol TanaseRadu Albulescu
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Dragan IlicPhilipp Dahm
Nov 16, 2019·Archives of Pathology & Laboratory Medicine·Chen Yang, Peter A Humphrey
Sep 5, 2020·Journal of Cancer Research and Clinical Oncology·Thomas WiegelMichael Stöckle
Aug 7, 2013·Virchows Archiv : an International Journal of Pathology·T Van der KwastUNKNOWN Pathology Committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
Nov 20, 2020·Journal of Clinical Pathology·Cornelia Margaret Szecsei, Jon D Oxley
Apr 28, 2021·The Journal of Pathology·Leonard M da SilvaJorge S Reis-Filho
May 2, 2021·Cancer Reports·Mohammad Sajjad Rahnama'iThomas Alexander Vögeli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.